AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
Cost-effectiveness of prenatal screening for postpartum thyroiditis
Authors: Bonds, DE Freedberg, KA
Citation: De. Bonds et Ka. Freedberg, Cost-effectiveness of prenatal screening for postpartum thyroiditis, J WOMEN H G, 10(7), 2001, pp. 649-658
Combining utility measurements - Exploring different approaches
Authors: Bonds, DE Freedberg, KA
Citation: De. Bonds et Ka. Freedberg, Combining utility measurements - Exploring different approaches, DIS MANAG H, 9(9), 2001, pp. 507-516
Investigation of primary human immunodeficiency virus infection in patients who test positive for heterophile antibody
Authors: Walensky, RP Rosenberg, ES Ferraro, MJ Losina, E Walker, BD Freedberg, KA
Citation: Rp. Walensky et al., Investigation of primary human immunodeficiency virus infection in patients who test positive for heterophile antibody, CLIN INF D, 33(4), 2001, pp. 570-572
Preevaluation of clinical trial data: The case of preemptive cytomegalovirus therapy in patients with human immunodeficiency virus
Authors: Paltiel, AD Goldie, SJ Losina, E Weinstein, MC Seage, GR Kimmel, AD Zhang, H Freedberg, KA
Citation: Ad. Paltiel et al., Preevaluation of clinical trial data: The case of preemptive cytomegalovirus therapy in patients with human immunodeficiency virus, CLIN INF D, 32(5), 2001, pp. 783-793
Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts
Authors: Yazdanpanah, Y Chene, G Losino, E Goldie, SJ Merchadou, LD Alfandari, S Seage, GR Sullivan, L Marimoutou, C Paltiel, AD Salamon, R Mouton, Y Freedberg, KA
Citation: Y. Yazdanpanah et al., Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts, INT J EPID, 30(4), 2001, pp. 864-871
Understanding delay to medical care for HIV infection: the long-term non-presenter
Authors: Samet, JH Freedberg, KA Savetsky, JB Sullivan, LM Stein, MD
Citation: Jh. Samet et al., Understanding delay to medical care for HIV infection: the long-term non-presenter, AIDS, 15(1), 2001, pp. 77-85
Cost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults
Authors: Schackman, BR Goldie, SJ Weinstein, MC Losina, E Zhang, H Freedberg, KA
Citation: Br. Schackman et al., Cost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults, AM J PUB HE, 91(9), 2001, pp. 1456-1463
The cost effectiveness of antiretroviral therapy for HIV disease. Reply
Authors: Freedberg, KA Losina, E Goldie, SJ
Citation: Ka. Freedberg et al., The cost effectiveness of antiretroviral therapy for HIV disease. Reply, N ENG J MED, 345(1), 2001, pp. 68-69
The cost effectiveness of combination antiretroviral therapy for HIV disease.
Authors: Freedberg, KA Losina, E Weinstein, MC Paltiel, AD Cohen, CJ Seage, GR Craven, DE Zhang, H Kimmel, AD Goldie, SJ
Citation: Ka. Freedberg et al., The cost effectiveness of combination antiretroviral therapy for HIV disease., N ENG J MED, 344(11), 2001, pp. 824-831
Use of genotypic resistance testing to guide HIV therapy: Clinical impact and cost-effectiveness
Authors: Weinstein, MC Goldie, SJ Losina, E Cohen, CJ Baxter, JD Zhang, H Kimmel, AD Freedberg, KA
Citation: Mc. Weinstein et al., Use of genotypic resistance testing to guide HIV therapy: Clinical impact and cost-effectiveness, ANN INT MED, 134(6), 2001, pp. 440-450
Positive Epstein-Barr virus heterophile antibody tests in patients with primary human immunodeficiency virus infection
Authors: Vidrih, JA Walensky, RP Sax, PE Freedberg, KA
Citation: Ja. Vidrih et al., Positive Epstein-Barr virus heterophile antibody tests in patients with primary human immunodeficiency virus infection, AM J MED, 111(3), 2001, pp. 192-194
Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus
Authors: Goldie, SJ Freedberg, KA Weinstein, MC Wright, TC Kuntz, KM
Citation: Sj. Goldie et al., Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus, AM J MED, 111(2), 2001, pp. 140-149
An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons
Authors: Kaplan, JE Masur, H Holmes, KK Freedberg, KA Holtgrave, D Piscitelli, SC Van Dyke, R Watts, H
Citation: Je. Kaplan et al., An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons, CLIN INF D, 30, 2000, pp. S15-S28
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Authors: Masur, H Kaplan, JE Holmes, KK Alston, BL Ampel, N Anderson, JR Baker, AC Barr, D Bartlett, JG Bennett, JE Benson, CA Bozzette, SA Chaisson, RE Crumpacker, CS Currier, JS Deyton, L Drew, WL Duncan, WR Eisinger, RW El-Sadr, W Feinberg, J Freedberg, KA Furrer, H Gnann, JW Goldberger, MJ Goldie, S Goosby, EP Gross, PA Hafner, R Havlir, D Hooton, TM Jabs, DA Jacobson, MA Janoff, E Kitahata, M Kovacs, JV Leport, C Levin, MJ Lopez, JC Marco, M Mayers, DL Melnick, DA Mofenson, LM Montaner, JSG Moore, R Neaton, J Nelson, C O'Neill, JF Palefsky, J Pau, A Phair, JP Piscitelli, S Polis, MA Quinn, TC Reiss, P Rimland, D Sears, CL Seeff, L Sepkowitz, KA Slama, TG Sloand, EM Spector, SA Thomas, DL Van Dyke, RB Watts, DH Wheat, LJ Whitcup, SM Williams, P Wright, TC Castro, KG DeCock, KM Dowell, SF Dworkin, MS Dykewicz, C Ellerbrock, T Hajjeh, R Holmberg, S Holtgrave, DR Jaffe, HW Jones, JL Juranek, DD Mast, E Navin, T Pellett, PE Reeves, WC Stewart, JA Villarino, ME
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, CLIN INF D, 30, 2000, pp. S29-S65
Performance measures for guidelines on preventing opportunistic infectionsin patients infected with human immunodeficiency virus
Authors: Gross, PA Asch, S Kitahata, MM Freedberg, KA Barr, D Melnick, DA Bozette, SA
Citation: Pa. Gross et al., Performance measures for guidelines on preventing opportunistic infectionsin patients infected with human immunodeficiency virus, CLIN INF D, 30, 2000, pp. S85-S93
Human immunodeficiency virus testing and behavior change - Reply
Authors: Freedberg, KA Samet, JH
Citation: Ka. Freedberg et Jh. Samet, Human immunodeficiency virus testing and behavior change - Reply, ARCH IN MED, 160(10), 2000, pp. 1539-1539
Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men
Authors: Goldie, SJ Kuntz, KM Weinstein, MC Freedberg, KA Palefsky, JM
Citation: Sj. Goldie et al., Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men, AM J MED, 108(8), 2000, pp. 634-641
Diagnosis and Treatment of Pneumocystis carinii Pneumonia: Economic issuesand cost-effectiveness
Authors: Goldie, SJ Freedberg, KA
Citation: Sj. Goldie et Ka. Freedberg, Diagnosis and Treatment of Pneumocystis carinii Pneumonia: Economic issuesand cost-effectiveness, SEM RESP CR, 20(3), 1999, pp. 213-220
The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDS
Authors: Scharfstein, JA Paltiel, AD Weinstein, MC Seage, GR Losina, E Craven, DE Freedberg, KA
Citation: Ja. Scharfstein et al., The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDS, INT J TE A, 15(3), 1999, pp. 531-547
Screening for malignant melanoma: A cost-effectiveness analysis
Authors: Freedberg, KA Geller, AC Miller, DR Lew, RA Koh, HK
Citation: Ka. Freedberg et al., Screening for malignant melanoma: A cost-effectiveness analysis, J AM ACAD D, 41(5), 1999, pp. 738-745
Are European-specific guidelines needed for prevention of opportunistic infections in HIV-1?
Authors: Yazdanpanah, Y Goldie, SJ Salamon, R Mouton, Y Freedberg, KA
Citation: Y. Yazdanpanah et al., Are European-specific guidelines needed for prevention of opportunistic infections in HIV-1?, LANCET, 354(9186), 1999, pp. 1305-1306
The cost-effectiveness of preventing AIDS-related opportunistic infections(vol 279, pg 130, 1998)
Authors: Freedberg, KA Scharfstein, JA Seage, GR Losina, E Weinstein, MC Craven, DE Paltiel, AD
Citation: Ka. Freedberg et al., The cost-effectiveness of preventing AIDS-related opportunistic infections(vol 279, pg 130, 1998), J AM MED A, 281(21), 1999, pp. 1989-1989
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men
Authors: Goldie, SJ Kuntz, KM Weinstein, MC Freedberg, KA Welton, ML Palefsky, JM
Citation: Sj. Goldie et al., The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men, J AM MED A, 281(19), 1999, pp. 1822-1829
Dermatologic manifestations in HIV-infected patients: A primary care perspective
Authors: Samet, JH Muz, P Cabral, P Jhamb, K Suwanchinda, A Freedberg, KA
Citation: Jh. Samet et al., Dermatologic manifestations in HIV-infected patients: A primary care perspective, MAYO CLIN P, 74(7), 1999, pp. 658-660
A population with short delay from diagnosis of human immunodeficiency virus to medical care - In reply
Authors: Samet, JH Freedberg, KA Stein, MD
Citation: Jh. Samet et al., A population with short delay from diagnosis of human immunodeficiency virus to medical care - In reply, ARCH IN MED, 159(7), 1999, pp. 759-759
Risultati: 1-25 | 26-29